Annexin Pharmaceuticals Reports First Patient Treated in the Second Dose Group in Annexin’s RVO Study
“During the autumn, we have visited several of our active [...]
Latest Study Demonstrates High Efficacy in Curing Invasive Non-melanoma Skin Cancer
Non-melanoma Skin Cancer: Treatment options include surgery, radiation, and cryotherapy. [...]
PharmaKure Submits MHRA CTA for Phase 2a Clinical Trial of PK051 in Patients with Mild Cognitive Impairment
PK051 is a combined drug that targets disaggregates of amyloid-β [...]
NICO Corporation Awards $40,000 Grant to London’s Kings College Hospital
To assess differences in the microstructural improvement of brain fiber [...]
Daye Announces Clinical Trial Launches to Develop Diagnostic Tampon for At-home STI and HPV Testing
Valentina Milanova, Founder of Daye, said: “Time is of the [...]
Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening
Utilizing Lunit INSIGHT MMG, an FDA-cleared and CE-marked AI solution [...]
SynerFuse™ Announces First Two-Level Integrated Spinal Fusion & DRG Neuromodulation Procedure by Solo Surgeon in Proof-of-Concept Study
“So far in the study, the SynerFuse procedure has been [...]
Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies
Boston Scientiic reports the results from the global, prospective, non-randomized, [...]
EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)
DynamX Bioadaptor is a new type of coronary implant designed [...]
Akura Medical Announces Successful First-in-Human Use of its High Performance Mechanical Thrombectomy Platform
While the use of mechanical thrombectomy devices has been increasing, [...]